Evaluates drug resistance in Mycobacterium tuberculosis using genomic surveillance and machine learning in Bangladesh, indicating new public health strategies.
Integrative Computational Profiling of Antimicrobial Resistance Genes and Machine Learning-Based Prediction of Drug-Resistant Mycobacterium tuberculosis in Bangladesh. Sifatullah Bilal Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) remains a critical public health emergency in Bangladesh, one of the 30 high-burden TB countries globally. This study presents the largest integrative whole-genome sequencing (WGS) and machine learning (ML) analysis of drug-resistant MTB in Bangladesh to date, combining WGS of 250 clinical isolates collected from all eight administrative divisions (2015–2025) with systematic antimicrobial resistance (AMR) gene profiling, statistical analysis, and multi-model ML classification. The cohort was dominated by lineages L2 (East Asian/Beijing; 44%) and L4 (Euro-American; 35.6%), with a combined MDR/Pre-XDR/XDR burden of 23.2%. rpoB mutations were detected in 41.6% of isolates, followed by katG (36%), embB (22.8%), and pncA (22.4%). Strong resistance co-occurrence was observed between rpoB–pncA (φ=0.61) and rpoB–embB (φ=0.60). Six machine learning classifiers were evaluated for binary MDR prediction; XGBoost achieved the highest performance (ROC-AUC: 0.974, F1: 0.959, MCC: 0.921). SHAP explainability analysis identified katG S315T, rpoB S450L, and rpoB H445Y as the dominant predictive biomarkers. Geographically, the Dhaka and Chittagong divisions showed disproportionately high MDR and Pre-XDR burdens. Novel findings include lineage-specific pncA enrichment in L2 isolates, a potential XDR micro-cluster in the Dhaka–Chittagong corridor, and retreatment case type as an independent ML predictor. These findings support the implementation of WGS-based genomic surveillance and explainable ML as a clinical framework for personalised TB treatment and targeted public health interventions in Bangladesh.
No takes yet. Share an insight, caveat, or question.
Bilal Sifatullah (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: